Related Experiment Videos
Topical metronidazole in seborrheic dermatitis--a double-blind study
1Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. dprs@vsnl.com
Dermatology (Basel, Switzerland)
|March 13, 2001
Summary
Topical 1% metronidazole gel significantly improved seborrheic dermatitis symptoms over 8 weeks. This study confirms metronidazole gel as an effective treatment for this common skin condition.
Area of Science:
- Dermatology
- Clinical Research
Background:
- Seborrheic dermatitis is a common chronic inflammatory skin condition.
- Current treatments have variable efficacy and potential side effects.
Purpose of the Study:
- To evaluate the efficacy of topical metronidazole gel in treating seborrheic dermatitis.
- To compare metronidazole gel with a placebo in a randomized controlled trial.
Main Methods:
- Forty-four patients with seborrheic dermatitis were randomized to receive either 1% metronidazole gel or placebo.
- Treatment was administered for 8 weeks with follow-up evaluations every 2 weeks.
- Severity scores and global improvement were assessed.
Main Results:
- A statistically significant reduction in seborrheic dermatitis severity scores was observed by week 2, with highly significant results by week 8 (p < 0.001).
- Marked improvement or complete clearance was achieved in 14/21 patients treated with metronidazole gel, versus 2/17 in the placebo group (p < 0.001).
Conclusions:
- Topical 1% metronidazole gel is an effective treatment for seborrheic dermatitis.
- The study demonstrates a significant clinical benefit of metronidazole gel for patients with this condition.